Metabolic disposition of tacrine in primary suspensions of rat hepatocyte and in single-pass perfused liver: in vitro/in vivo comparisons

References

• Bezek Š., Kukan M., Kallay Z., Trnovec T., Štefek M., Piotrovskiy L. B. Disposition of ethimizol, a xanthine‐related nootropic drug, in perfused rat liver and isolated hepatocytes. Drug Metabolism and Disposition 1990; 18: 88–95
   PubMed Web of Science ®Google Scholar
• Farlow M., Gracon S. I., Hershey L. A., Lewis K. W., Sadowsky C. H., Eolan‐Ureno J. A controlled trial of tacrine in Alzheimer's disease. Journal of the American Medical Association 1992; 268: 2523–2529
   PubMed Web of Science ®Google Scholar
• Hartvig P., Askmark H., Aquilonius S. M., Wiklund L., Lindstrom B. Clinical pharmacokinetics of intravenous and oral 9‐amino‐1,2,3,4‐tetrahydroacridine, tactrine. European Journal of Clinical Pharmacology 1990; 38: 259–263
   PubMed Web of Science ®Google Scholar
• Horvath T. Drug metabolism in drug‐induced liver diseases: pathogenetic role of active metabolites. Acta Physiologica Hungarica 1989; 73: 293–304
   PubMedGoogle Scholar
• Hsu R. S., Shutske G. M., Dileo E. M., Chesson S. M., Linville A. R., Allen R. C. Identification of the urinary metabolites of tacrine in the rat. Drug Metabolism and Disposition 1990; 18: 779–783
   PubMedGoogle Scholar
• Knapp M. J., Knopman D. S., Solomon P. R., Pendlebury W. W., Davis C. S., Gracon S. I. A 30‐week randomized controlled trial of high‐dose tacrine in patients with Alzheimer's disease. Journal of the American Medical Association 1994; 271: 985–991
   PubMed Web of Science ®Google Scholar
• Kukan M., Bezek Š., Štefek M., Trnovec T., Ďurišová M., Piotrovskiy L. B. The effect of enzyme induction and inhibition on the disposition of the xanthine‐related nootropic drug ethimizol in perfused liver and hepatocytes of rats. Drug Metabolism and Disposition 1990; 18: 96–101
   PubMedGoogle Scholar
• Kukan M., Bezek Š., Pool W. F., Woolf T. F. In vitro/in vivo correlations in tactrine metabolism and its stimulation by 3‐methylcholanthrene. Presented at the Fourth European ISSX Meeting, BolognaItaly, July, 3–61992. ISSX, Bethesda, MD
   Google Scholar
• Madden S., Pool W. F., Woolf, Park B. K. An investigation into the formation of stable, protein‐reactive and cytotoxic metabolites from tacrine in vitro: studies with human and rat liver microsomes. Biochemical Pharmacology 1993; 46: 13–20
   PubMed Web of Science ®Google Scholar
• Neuberger J., Williams R. Immune mechanism in tienilic acid associated hepatotoxicity. Gut 1989; 30: 515–519
   PubMed Web of Science ®Google Scholar
• O'Brien J. T., Eagger S., Levy R. Effects of tetrahydroaminoacridine on liver function in patients with Alzheimer's disease. Age and Ageing 1991; 20: 129–131
   PubMedGoogle Scholar
• Pang K. S., Rowland M. Hepatic clearance of drugs. I. Theoretical considerations of a ‘well‐stirred’ model and a ‘parallel tube’ model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. Journal of Pharmacokinetics and Biopharmaceutics 1977; 5: 625–653
   PubMedGoogle Scholar
• Pessayre D. Cytochromes P450 and formation of reactive metabolites. Role in drug‐induced hepatotoxicity. Therapie 1993; 48: 537–548
   PubMed Web of Science ®Google Scholar
• Pool W. F., Bjorge S. M., Windsor B., Black A., Chang T., Woolf T. F. Comparison of brain to plasma metabolic distributions of tacrine and 1‐hydroxytacrine in rat. Presented at the Society for Neuroscience 21st Annual Meeting, New Orleans, Louisiana, November, 10–151991. ISSX, Bethesda, MD
   Google Scholar
• Pool W. F., Bjorge S. M., Reily M. D., Chang T., Woolf T. F. Metabolic disposition of the cognition activator tacrine in dog: identification of dihydroxy metabolites including a dihydrodiol. Presented at the Fourth North American ISSX Meeting, Bal Harbour, Florida, November, 2–6. ISSX, Bethesda, MD 1992a
   Google Scholar
• Pool W. F., Bjorge S. M., Reily M. D., Chang T., Woolf T. F. Metabolic disposition of the cognition activator tacrine in man: identification of phenol glucuronide metabolites in urine. Presented at the Fourth North American ISSX Meeting, Bal Harbour, Florida, November, 2–6. ISSX, Bethesda, MD 1992b
   Google Scholar
• Pool W. F., Bjorge S. M., Chang T., Woolf T. F. Effect of 3‐methyl cholanthrene induction of the disposition of the cognition activator tacrine in rat. Presented at the Fourth North American ISSX Meeting, Bal Harbour, Florida, November, 2–6. ISSX, Bethesda, MD 1992c
   Google Scholar
• Seglen P. O. Preparation of isolated rat liver cells. Methods in Cell Biology 1976; 13: 29–83
   PubMedGoogle Scholar
• Sies H. The use of perfusion of liver and other organs for the study of microsomal electron‐transport and cytochrome P‐450 systems. Methods in Enzymology 1978; 52: 48–59
   PubMedGoogle Scholar
• Spaldin V., Madden S., Pool W. F., Woolf T. F., Park B. K. The effect of enzyme inhibition on the metabolic activation of tacrine by human liver microsomes. British Journal of Clinical Pharmacology 1994; 38: 15–22
   PubMed Web of Science ®Google Scholar
• Spector T. Refinement of the coomassie blue method of protein quantitation. Analytical Biochemistry 1978; 86: 142–146
   PubMed Web of Science ®Google Scholar
• Watkins P. B., Zimmerman H. J., Knapp M. J., Gracon S. I., Lewis K. W. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. Journal of the American Medical Association 1994; 271: 992–998
   PubMed Web of Science ®Google Scholar
• Wilkinson G. R., Shand D. G. A physiological approach to hepatic drug clearance. Clinical Pharmacology and Therapeutics 1975; 18: 377–390
   PubMed Web of Science ®Google Scholar
• Woolf T. F., Pool W. F., Bjorge S. M., Chang T., Goel O. P., Purchase C. F., Schroeder M. C., Kunze K. L., Tracer W. F. Bioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations: species differences. Drug Metabolism and Disposition 1993; 21: 874–882
   PubMed Web of Science ®Google Scholar
• Zhalten R. N., Stratman F. W. The isolation of hormone‐sensitive rat hepatocytes by a modified enzymatic technique. Archives of Biochemistry and Biophysiology 1974; 163: 600–608
   PubMedGoogle Scholar